Alzheon – Framingham Source

Framingham Company Developing Alzheimer’s Disease Treatments Launches Initial Public Offering

April 2, 2018April 4, 2018 Framingham Source Editor Susan Petroni 0 Comments Alzheimer's disease treatments, Alzheon, initial public offering, NASDAQ, Stock

Shares 0

FRAMINGHAM – Alzheon, Inc. announced today, April 2, it has launched the roadshow for the initial public offering of its common stock.

Business

FDA Fast Tracks Framingham Company’s Drug To Treat Alzheimer’s Disease

October 26, 2017October 26, 2017 Framingham Source Editor Susan Petroni 0 Comments ALZ-801, Alzheon, Food and Drug Administration (FDA)

Shares 0

FRAMINGHAM – Alzheon, Inc., a clinical stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and

Business

Framingham-Based Alzheon Appoints Chief Business Officer

February 28, 2017March 3, 2017 Framingham Source Editor Susan Petroni 0 Comments Alzheon, Neil Flanzraich

Shares 0

FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and